Regeneron Pharmaceuticals
REGN
#192
Rank
S$120.82 B
Marketcap
$1,099
Share price
0.48%
Change (1 day)
1.12%
Change (1 year)

EPS for Regeneron Pharmaceuticals (REGN)

EPS in 2023 (TTM): $50.37

According to Regeneron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $49.58. In 2022 the company made an earnings per share (EPS) of $53.78 a decrease over its 2021 EPS that were of $101.47.

EPS history for Regeneron Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$50.37-6.34%
2022$53.78-47%
2021$101.47133.36%
2020$43.4869.13%
2019$25.71-14.44%
2018$30.05100.71%
2017$14.9731.78%
2016$11.3638.96%
2015$8.1872.55%
2014$4.74-17.55%
2013$5.75-44.98%
2012$10.45-422.54%
2011-$3.2492.13%
2010-$1.6949.41%
2009-$1.13-15.84%
2008-$1.34-36.88%
2007-$2.12-9.6%
2006-$2.354.12%
2005-$2.26-323.68%
2004$1.01-135.51%
2003-$2.84-24.38%
2002-$3.7656.35%
2001-$2.40187.3%
2000-$0.84-16%
1999-$1.00177.78%
1998-$0.36-35.71%
1997-$0.56-68.42%
1996-$1.77

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$18.78-62.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-$5.45-111.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$24.50-50.59%๐Ÿ‡บ๐Ÿ‡ธ USA
$18.69-62.30%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.96-89.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$4.22-91.49%๐Ÿ‡ซ๐Ÿ‡ท France